Publications by the researcher in collaboration with Gema Fruhbeck Martínez (126)

2022

  1. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement

    Obesity Facts, Vol. 15, Núm. 3, pp. 321-335

  2. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement

    Clinical Nutrition, Vol. 41, Núm. 4, pp. 990-1000

2021

  1. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling

    Cellular and Molecular Immunology, Vol. 18, Núm. 4, pp. 1045-1057

  2. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum Leptin levels

    Nutrients, Vol. 13, Núm. 4

2020

  1. Aquaporin-11 Contributes to TGF-β1-Induced Endoplasmic Reticulum Stress in Human Visceral Adipocytes: Role in Obesity-Associated Inflammation

    Cells, Vol. 9, Núm. 6

  2. Dermatopontin, a novel adipokine promoting adipose tissue extracellular matrix remodelling and inflammation in obesity

    Journal of Clinical Medicine, Vol. 9, Núm. 4

  3. FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes

    Metabolism: Clinical and Experimental, Vol. 108

  4. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

  5. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2019

  1. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation

    Nutrients, Vol. 11, Núm. 2

  2. Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes

    Aging, Vol. 11, Núm. 6, pp. 1733-1744

  3. Circulating concentrations of GDF11 are positively associated with TSH levels in humans

    Journal of Clinical Medicine, Vol. 8, Núm. 6

  4. Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: The DICAMANO Study NCT03506581 NCT

    Journal of Translational Medicine, Vol. 17, Núm. 1

  5. GLP-1 limits adipocyte inflammation and its low circulating pre-operative concentrations predict worse type 2 diabetes remission after bariatric surgery in obese patients

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  6. Hypothalamic dopamine signalling regulates brown fat thermogenesis

    Nature Metabolism, Vol. 1, Núm. 8, pp. 811-829

  7. Increase of the adiponectin/leptin ratio in patients with obesity and type 2 diabetes after roux-en-y gastric bypass

    Nutrients, Vol. 11, Núm. 9

  8. Is pharmacotherapy enough for urgent weight loss in severely obese patients?

    Expert Opinion on Pharmacotherapy

  9. New advances and novel approaches in obesity pharmacotherapy

    Current Opinion in Endocrine and Metabolic Research, Vol. 4, pp. 75-82

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

  2. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

    Obesity, Vol. 26, Núm. 4, pp. 672-682